Share with your friends

FDA Approves First-of-its-Kind Intentional Genomic Alteration in Line of Domestic Pigs

FDA Approves First-of-its-Kind Intentional Genomic Alte

Field Notes, powered by KPMG, is a weekly news update on news nationally and globally from the agri-food sector.

Ian Proudfoot

Global Head of Agribusiness, Partner - Audit

KPMG in New Zealand


Also on


[14 December, PR Newswire]

The US Food and Drug Administration (FDA) approved an intentional genomic alteration (IGA) in a line of domestic pigs, referred to as GalSafe pigs. The IGA is intended to eliminate alpha-gal sugar on the surface of the pigs' cells in order to reduce the allergic reactions from people with Alpha-gal syndrome when consuming red meat. This is a first-of-its-kind IGA approved by the FDA for the purpose of food consumption and as a source for potential therapeutic uses.

To read this week's full edition of Field Notes, please click here.

To read the full original article, please click here.


© 2021 KPMG, a New Zealand Partnership and a member firm of the KPMG global organisation of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved.

For more detail about the structure of the KPMG global organization please visit

Connect with us


Want to do business with KPMG?


loading image Request for proposal